Prisca Honore

Prisca Honore publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Prisca Honore sits on this spectrum.

Prisca Honore D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Prisca Honore sits on this spectrum.

Overview

Best Publications

• Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

  Patrick W. Mantyh;Scott D. Rogers;Scott D. Rogers;Prisca Honore;Prisca Honore;Brian J. Allen;Brian J. Allen

  735
  Citations

• Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain

  Matthew J. Schwei;Prisca Honore;Scott D. Rogers;Janeen L. Salak-Johnson

  706
  Citations

• Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

  P Honore;S.D Rogers;M.J Schwei;J.L Salak-Johnson

  704
  Citations

• A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

  Michael F. Jarvis;Prisca Honore;Char Chang Shieh;Mark Chapman

  638
  Citations

• Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

  Prisca Honore;Nancy M. Luger;Nancy M. Luger;Mary Ann C. Sabino;Mary Ann C. Sabino;Matthew J. Schwei;Matthew J. Schwei

  619
  Citations

• A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat

  Prisca Honore;Diana Donnelly-Roberts;Marian T. Namovic;Gin Hsieh

  573
  Citations

• A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

  Michael F. Jarvis;Edward C. Burgard;Steve McGaraughty;Prisca Honore

  560
  Citations

• Transmission of chronic nociception by spinal neurons expressing the substance P receptor.

  Michael L. Nichols;Michael L. Nichols;Brian J. Allen;Brian J. Allen;Scott D. Rogers;Scott D. Rogers;Joseph R. Ghilardi;Joseph R. Ghilardi

  526
  Citations

• TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists

  M. Cui;P. Honore;C. Zhong;D. Gauvin

  394
  Citations

• A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

  Prisca Honore;Carol T Wismer;Joseph P Mikusa;Chang Z Zhu

  377
  Citations

• Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

  Prisca Honore;Karen Kage;Joseph Mikusa;Andrew T. Watt

  322
  Citations

• Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists

  Derek W. Nelson;Robert J. Gregg;Michael E. Kort;Arturo Perez-Medrano

  287
  Citations

• Osteoprotegerin Diminishes Advanced Bone Cancer Pain

  Nancy M. Luger;Prisca Honore;Mary Ann C. Sabino;Matthew J. Schwei

  284
  Citations

• Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain.

  Nancy M. Luger;Mary Ann C. Sabino;Matthew J. Schwei;David B. Mach

  282
  Citations

• P2X7-related modulation of pathological nociception in rats

  S. McGaraughty;K.L. Chu;M.T. Namovic;D.L. Donnelly-Roberts

  275
  Citations

• Effects of A‐317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

  Steve McGaraughty;Carol T Wismer;Chang Z Zhu;Joseph Mikusa

  257
  Citations

• Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.

  S K Joshi;Joseph P Mikusa;Gricelda Hernandez;Scott Baker

  256
  Citations

• Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States

  Prisca Honoré;Prisca Honoré;Patrick M. Menning;Patrick M. Menning;Scott D. Rogers;Scott D. Rogers;Michael L. Nichols;Michael L. Nichols

  254
  Citations

• Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels.

  G.R. Dubé;Sonya G. Lehto;Nicole M. Breese;Scott J. Baker

  251
  Citations

• Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

  Arthur Gomtsyan;Erol K Bayburt;Robert G Schmidt;Guo Zhu Zheng

  225
  Citations